- Home
- / Innovent Biologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Innovent Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$37.2
2024-10-29
Market Capitalization
$57.6 B
2024-10-29
Revenue
¥13 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.5M | 1.0B | 3.8B | 4.3B | 4.6B | 6.2B | 9.4B | 13.0B |
| Cost of goods sold | 124.9M | 266.5M | 300.6M | 611.6M | 751.2M | 937.2M | 1.1B | |
| Gross profit | 82.6M | 964.0M | 3.7B | 4.0B | 4.0B | 5.6B | 8.6B | 12.0B |
| Gross profit margin, % | 92.0% | 96.5% | 94.0% | 88.6% | 89.5% | 91.2% | 92.3% | |
| Operating expense total | 1.6B | 2.7B | 4.0B | 6.5B | 6.7B | 6.6B | 8.2B | 10.6B |
| Depreciation and amortization | 62.8M | 86.4M | 121.3M | 204.7M | 319.4M | 500.5M | 1.1B | 632.8M |
| EBITDA | (1.5B) | (1.7B) | (305.2M) | (2.5B) | (2.7B) | (1.1B) | 367.9M | 1.4B |
| EBITDA margin, % | -161.5% | -7.9% | -57.5% | -59.5% | -17.4% | 3.9% | 10.4% | |
| EBIT | (5.9B) | (1.8B) | (427.7M) | (2.7B) | (3.0B) | (1.6B) | (707.4M) | 726.1M |
| EBIT margin, % | -169.8% | -11.1% | -62.3% | -66.5% | -25.5% | -7.5% | 5.6% | |
| Interest income | 20.7M | 102.7M | 116.1M | 151.8M | 189.5M | 452.8M | 423.5M | 438.7M |
| Interest expense | 69.0M | 59.5M | 68.4M | 62.5M | 101.7M | 98.6M | 67.6M | 79.6M |
| Pre tax profit | (5.9B) | (1.7B) | (858.7M) | (2.6B) | (2.2B) | (1.1B) | (78.6M) | 838.9M |
| Income tax expense | 139.7M | 87.0M | 8.8M | (116.5M) | 16.0M | 25.4M | ||
| Net Income | (5.9B) | (1.7B) | (998.4M) | (2.7B) | (2.2B) | (1.0B) | (94.6M) | 813.6M |